Rucaparib,Nivolumab
BMS,clovis oncology
['rucaparib']
just in from #asco22! athena-mono demonstrated the potential of rucaparib as 1l maintenance following platinum-based chemo. compared to placebo, pfs was significantly improved in both the hrd (28.7mo vs 11.3mo) and itt (20.2mo vs 9.2mo) populations 